Wells Fargo
IMNM icon

Wells Fargo’s Immunome IMNM Stock Holding History

Wells Fargo’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Buy
101,394
+59,640
+143% +$1.28M ﹤0.01% 3542
2026
Q1 		$913K Sell
41,754
-66,361
-61% -$1.48M ﹤0.01% 3787
2025
Q4 		$2.32M Buy
108,115
+56,700
+110% +$995K ﹤0.01% 3320
2025
Q3 		$602K Buy
51,415
+9,654
+23% +$96K ﹤0.01% 4159
2025
Q2 		$388K Buy
41,761
+5,661
+16% +$46.4K ﹤0.01% 4327
2025
Q1 		$243K Buy
36,100
+9,893
+38% +$94.9K ﹤0.01% 4567
2024
Q4 		$278K Buy
26,207
+8,190
+45% +$99K ﹤0.01% 4583
2024
Q3 		$263K Sell
18,017
-526
-3% -$7.47K ﹤0.01% 4394
2024
Q2 		$224K Buy
18,543
+14,329
+340% +$224K ﹤0.01% 4442
2024
Q1 		$104K Buy
4,214
+2,196
+109% +$44.6K ﹤0.01% 4872
2023
Q4 		$21.6K Buy
2,018
+170
+9% +$1.41K ﹤0.01% 5614
2023
Q3 		$15.4K Sell
1,848
-9
-0.5% -$66 ﹤0.01% 5687
2023
Q2 		$14.7K Buy
1,857
+3
+0.2% +$16 ﹤0.01% 5819
2023
Q1 		$9.25K Buy
1,854
+1
+0.1% +$5 ﹤0.01% 5886
2022
Q4 		$4.09K Buy
1,853
+2
+0.1% +$8 ﹤0.01% 5827
2022
Q3 		$8K Sell
1,851
-1
-0.1% -$5 ﹤0.01% 5762
2022
Q2 		$6K Buy
1,852
+6
+0.3% +$22 ﹤0.01% 5947
2022
Q1 		$10K Buy
1,846
+1,785
+2,926% +$13.3K ﹤0.01% 6266
2021
Q4 		$1K Buy
61
+2
+3% +$36 ﹤0.01% 7021
2021
Q3 		$1K Buy
59
+30
+103% +$523 ﹤0.01% 6718
2021
Q2 		$1K Sell
29
-635
-96% -$14K ﹤0.01% 6672
2021
Q1 		$22K Sell
664
-619
-48% -$15.4K ﹤0.01% 6117
2020
Q4 		$12K Buy
+1,283
New +$15K ﹤0.01% 5982

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Wells Fargo's IMNM Position: Q2 2026 in Review

Wells Fargo increased its Immunome (IMNM) stake by 143% in Q2 2026, buying an estimated $1.28M and bringing the position to 101,394 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

Wells Fargo first reported a position in IMNM in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.32M in Q4 2025. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Wells Fargo held 101,394 shares of Immunome worth $2.15M as of Q2 2026.
  • Wells Fargo bought 59,640 Immunome shares in Q2 2026, an estimated $1.28M.
  • Immunome made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3542 holding.
  • Wells Fargo first reported a position in Immunome in Q4 2020 and has held it in 23 quarters since.
  • Wells Fargo's Immunome position peaked at $2.32M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.